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10.8% vs. 12.1%, p0.0001). There was no difference in DES use between the groups
(46.7% vs. 42.7% vs. 43.4%, p0.84). Cardiogenic shock on presentation (14.8% vs.
12.8% vs. 4.7%, p0.0001), and in-hospital mortality (7.9% vs. 6.4% vs. 1.8%, p0.001)
were highest in the government-sponsored group followed by private and uninsured
groups.
Conclusion: This study demonstrates that insurance type is associated with significant
differences at baseline (clinical, demographic and procedural characteristics) and hospital
outcomes in patients with AMI with PCI.
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Young Patients With Acute Myocardial Infarction: How Are They Different?
Nirav Desai, G. Andres Cortes, Kenneth Kita, Nazila Rad, David M Shavelle,
Anilkumar Mehra, Michael A Gaglia, JR., Ray V Matthews, Leonardo Clavijo
University of Southern California, Los Angeles, CA
Background: The goal of the study is to investigate baseline risk factors, coronary artery
angiogram results and interventions, and hospital outcomes in young patients with acute
myocardial infarction (less than 45 years vs. older than 45 years of age).
Method: Retrospective analysis of 779 patients treated with PCI for acute myocardial
infarction (AMI) at the Los Angeles County Hospital USC Medical Center and Keck
Medical Center of USC between January 2008 and June 2011. Patients were divided into
2 groups according to age 81 young patients and 698 older patients. Baseline demograph-
ics, clinical characteristics, coronary angiogram results, PCI procedural information and
hospital outcomes were compared.
Results: Young patients ( 45 years old) represented 10.3% (n81) of the total patient
population (779 patients). Younger patients were found to have lower rates of diabetes
(22.2% vs. 35.6%, p-value 0.03), more likely to be males (87.6% vs. 76%, p-value 0.02) and
have higher triglyceride levels (212 mg/dl vs. 153.4 mg/dl, p-value 0.014). Young patients
were less likely to have hypertension (41.8% vs. 66.8%, p-value  0.0001). Both groups
had similar rates of NSTEMI (44.4% vs. 49.7%, p-value 0.37) and STEMI (55.6% vs.
50.3%, p-value 0.37). Single vessel coronary artery disease was more prevalent in the
younger group (71.7% vs. 44.6%, p-value0.001) and had a higher rate of total occlusion
of the infarct-related artery (39.7% vs. 19.1%, p-value 0.003). Rates of percutaneous
coronary artery interventions (97.5% vs. 94%, p-value 0.3) and number coronary artery
stent placement (1.5 vs. 1.8, p-value 0.26) were similar between both groups, while the
younger group had a lower rate of post-intervention acute renal failure (1.4% vs. 9.5%,
p-value 0.02). Length of total hospital stay (4.6 days vs. 6 days, p-value 0.15) and intensive
care unit stay (2.9 days vs. 3.6 days, p-value 0.32) was also similar.
Conclusion: Younger age in patients with AMI is associated with male predom-
inance, higher triglyceride levels, and higher rates of single vessel disease and total
occlusion of the infarct related artery. Younger patients had a lower rate of
post-procedure renal failure, while the remaining post-procedural outcomes and
in-hospital mortality were similar.
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Chronic Pretreatment of Angiotensin Converting Enzyme Inhibitor Decreases
In-hospital Adverse Events in Diabetic Hypertensive Patients with Acute Myocardial
Infarction
Seo Na Hong,1 Nam Sik Yoon,2 Youngkeun Ahn,2 Myung Ho Jeong2
1Seonam university hospital, Gwangju, Korea, Republic of 2Chonnam national
university hospital, Gwangju, Korea, Republic of
Background: Angiotensin converting enzyme inhibitor (ACEI) or angiotensin
receptor blocker was commonly used in patients who have hypertension and
diabetes. The aim of this study was to evaluate the effect of chronic pretreatment
of ACEI or ARB before development of acute myocardial infraction (AMI) for in
hospital outcome after AMI.
Methods: A total of 1369 diabetic-hypertensive patients (66.710.8 years, male 59.2 %)
with AMI (739 ST segment elevation MI and 630 non-ST segment elevation MI) who
were registered in Korea Acute Myocardial Infarction Registry from Nov. 2005 to Aug
2007. were enrolled. We excluded patients with chronic renal failure and chronic heart
failure. The patients were divided into three groups: the patients with chronic pretreat-
ment of ACEI (group I, n148), the patients with chronic pretreatment of ARB (group
II, n175), and patients without pretreatment of ACEI or ARB (group III, n1046).
The clinical characteristics and in-hospital adverse events (IHAEs) were compared among
the groups.
Results: The baseline clinical characteristics were similar among three groups including
clinical diagnosis, Killip class, laboratory parameters, strategy of treatment and angio-
graphic findings. The group I had the lowest rate of IHAEs among the groups (group I:
9.2% vs. group II: 24.8% vs. group III: 17.6%, p0.010). As compared with the group III,
the group I had significantly lower rate of IHAEs (9.2% vs. 17.6%, p0.003), but group
II had significantly higher rate of IHAEs (24.8% vs. 17.6%, p0.049). In Cox
proportional hazard regression analysis, chronic pretreatment of ACEI (RR: 0.474, 95%
CI 0.234-0.958, p0.037) and ARB (RR: 3.261, 95% CI 1.470-7.234, p0.004) were
associated with IHAEs in diabetic hypertensive patient with AMI.
Conclusion: Chronic pretreatment of ACEI decreases IHAEs but that of ARB
increases IHAEs in diabetic hypertensive patient with AMI.
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Apolipoprotein B And Apolipoprotein B/a1 Ratio Are Related To Total Occlusion Of
Infarct-related Artery In Non-diabetic Patients With Acute Non-st Elevation
Myocardial Infarction
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Background: Insulin resistance (IR) is an associated with a significant increase in the risk
of coronary artery disease. The serum Apolipoprotein B (Apo B) and Apo B/Apo-I ratio
are important markers of IR in non-diabetic, normoglycemic subjects. We investigated
the role of Apo B and ApoB/Apo A1 ratio in patients with acute Non-ST elevation
myocardial infarction (NSTEMI) with total occlusion (TO) of infarct-related artery
(IRA).
Methods: A total of 280 patients (64.512.7 years, male 70 %) with acute NSTEMI
who were underwent percutaneous coronary intervention were enrolled. We excluded
patients with history of diabetes, or medication of oral hypoglycemics, or hemoglobin A1c
(HbA1c) more than 6.5%. The patients were divided into two groups according to the
finding of IRA (Group I: patients with TO of IRA, n84; Group II: patients with
non-TO of IRA, n196).
Results: The level of troponin I are significantly higher in Group I than in Group II
(83.330.1 vs. 71.633.7 ng/mL, p0.044). Most frequent IRA was left circumflex
artery in Group I (50%) and Group I had more complex vascular lesion compared with
Group II (Type C lesion 64.3% vs. 29.0%, p0.001). The level of Apo B and Apo B/Apo
A1 ratio were significantly higher in Group I than in Group II (108.125.3 vs.
96.325.4, p0.019; 0.870.21 vs. 0.740.22, p0.004, respectively). Group I was
divided into two subgroups according to initial therapeutic strategy. In subgroup analysis,
early invasive treatment group had lower in-hospital adverse events than in early
conservative treatment group (5.7% vs. 10.1%, p0.046). In multivariate analysis, elevated
Apo B/Apo A1 ratio showed high probability of TO of IRA (odd ratio, 3.56; 95% CI,
1.12 to 11.38, p0.031).
Conclusions: The level of Apo B and Apo B/Apo A1 ratio were associated TO of IRA
in patients with acute NSTEMI. The markers may be useful for choice of initial
therapeutic strategy in acute NSTEMI.
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What Are The Correlates For Mortality In Patients Presented With Acute Myocardial
Infarct Complicated By Cardiogenic Shock?
Sa’ar Minha, Israel M Barbash, Danny Dvir, Itsik Ben-Dor, Joshua P Loh,
Salem M Badr, Hironori Kitabata, Lakshmana K Pendyala, Lowell F Satler,
Augusto D Pichard, Kenneth M Kent, William Suddath, Rebecca Torguson,
Ron Waksman
Medstar Washington Hospital Center, Washington, DC
Introduction: Acute myocardial infarction (AMI) complicated by cardiogenic shock
(CS) is associated with high mortality rates. This study aimed to explore the correlates for
mortality in patients presented in CS complicating an AMI who were treated with
primary percutaneous intervention (PPCI) and intra-aortic balloon pump counterpulsa-
tion (IABP).
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Methods: The study compared patients who died in-hospital to those who survived to
discharge in a cohort of 93 patients meeting strict definitions for CS to identify correlates
associated with mortality.
Results: The overall in-hospital mortality rate for the study cohort was 33%. The
baseline characteristics were balanced except for older average age and left ventricular
ejection fraction in those who died (p0.049 and p0.014, respectively). As detailed in
the Table, the insertion of IABP pre-PCI, cardiac arrest at the catheterization lab, and
lower ejection fraction (EF) were all correlated with in-hospital mortally (odd ratios 2.68,
5.93 and 0.02, respectively).
Conclusions: In the era of PPCI and IABP as standard of care in AMI complicated by
CS, patients with low EF, those who necessitate IABP insertion pre-PCI and those who
necessitated CPR during PCI are at higher risk for in-hospital mortality and should be
considered for more robust devices (e.g. assisted devices) with an attempt to improve their
prognosis.
Table 1. The demographic and clinical characteristics of patients with
AMI complicated by CS.
Variable
Odds Ratio
(95% CI)
Lower OR-
Upper OR P Value
Age 1.04 1-1.07 0.053
Men 0.87 0.35-2.15 0.756
Diabetes mellitus 1.23 0.5-3.01 0.646
Body mass index 0.91 0.83-1 0.059
Ejection fraction (%) 0.02 0-0.5 0.018
Number of diseased vessels 1.54 0.92-2.6 0.102
IABP pre PCI 2.68 1.11-6.52 0.029
Pre-hospital CS 0.183 0.76-4.33 1.81
CPR in the catheterization
laboratory
5.93 1.66-21.2 0.006
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Comparison Of Outcomes Of Patients Presenting With Inferior STEMI With Proximal
And Distal Right Coronary Artery Obstruction
Manu Kaushik, Alok Saurav, Satish Chandraprakasam, Anand Deshmukh,
Michael Del Core, Aryan Mooss, Dennis Esterbrooks
Creighton University School of Medicine, Omaha, NE
Background: While, proximal right coronary artery (RCA) occlusion in patients with
inferior STEMI would suggest right ventricular involvement, the effect of location of
RCA occlusion on outcomes has not been studied. We sought to evaluate the impact of
site of occlusion of RCA on outcomes of patients with inferior STEMI undergoing PCI.
Methods: All patients presenting to a tertiary care center between June 2006 and May
2012 with STEMI and undergoing PCI with RCA as the culprit vessel were included.
Patients with proximal RCA occlusion were compared to patients with distal RCA
occlusion. Lesion location was determined based on whether the occlusion was proximal
or distal to major right ventricular branch take-off. Patients with posterior descending
branch or posterolateral branch occlusion were excluded to correct for left ventricular
myocardium at risk in both comparison groups. Clinical and outcome variables were
retrieved from retrospective chart review.
Results: One hundred, ninety-seven patients were included in final analysis of which, 94
patients had proximal RCA and 103 had distal RCA occlusion. There were no significant
differences between the two groups with respect to gender, prevalence of hypertension,
hyperlipidemia (HL), diabetes mellitus (DM), smoking, chronic pulmonary disease and
timely revascularization. Twenty-four patients were treated with PTCA, while 173
patients were treated with stenting. Major adverse cardiovascular events (MACE) defined
as combined incidence of cardiogenic shock, IABP use, cardiac arrest and death was
similar in the two groups (21.3% vs. 18.4%; p 0.05). Individual event rates for
cardiogenic shock, IABP use, death, cardiogenic shock and hypotension were also
statistically similar in both groups. Post STEMI left ventricular function was similar in
both groups (46.8 vs 47.2%; p 0.77) as was the duration of hospitalization (5.06 vs. 5.17
days; p 0.75). No clinical variables (gender, hypertension, DM, smoking, HL, chronic
pulmonary disease, etc.) predicted MACE. However, time to revascularization 6 hours
from symptom onset showed a statistical trend towards predicting MACE (OR0.50
[95% CI 0.24-1.05], p  0.06).
Conclusions: In patients presenting with inferior STEMI treated with PCI, location of
occlusion with respect to the right ventricular branch origin does not predict major adverse
cardiovascular events Proximal lesion location in right coronary artery should not be used
as a surrogate for clinically significant right ventricular involvement in STEMI patients.
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Prediction Of Multivessel Disease In STEMI Patients
Eric Bansal, Nazila Rad, Andres Cortes, Brittany Wagman, Kenneth Kita, Han Tun,
Ray Matthews, Anilkumar Mehra, Michael Gaglia, Leonardo Clavijo, David Shavelle
University of Southern California, Los Angeles, CA
Background: Although early loading of antiplatelet therapy is beneficial for STEMI
patients, it may cause bleeding complications in patients with multivessel coronary artery
disease (MVD) requiring coronary artery bypass surgery. The identification of MVD in
STEMI patients using the initial electrocardiogram (ECG) would be beneficial. We
therefore investigated the ability of the initial ECG to predict MVD in STEMI patients.
Methods: From January, 2008 through December, 2010, 224 patients undergoing
primary PCI for STEMI were evaluated. Baseline demographics, ECG findings,
angiographic findings and in-hospital clinical events were collected. ECG findings
included the amount of ST segment elevation and/or depression in mm in all ECG leads
and the total number of leads with  1 mm ST segment elevation and/or ST segment
depression. MVD was defined as  2 coronary vessels with  70% luminal diameter
stenosis; single vessel disease (SVD) was defined as 1 coronary vessel with 70% luminal
diameter stenosis. Patients with SVD (n106) were compared to those with MVD
(n118) and predictors of MVD disease were evaluated using multiple logistic regression
analysis.
Results: Patients with MVD had a higher prevalence of hypertension, hyperlipidemia,
diabetes mellitus, metabolic syndrome and a family history of CAD compared to those
with SVD. The left anterior descending artery was more commonly the infarct related
artery in patients with SVD compared to the right coronary artery in patients with MVD.
In-hospital MACE rates were significantly higher in patients with MVD compared to
those with SVD, 30.5% versus 17.9%, p 0.03, respectively. Hyperlipidemia, hypertension,
diabetes mellitus, total ST segment changes 6 mm and total number of ECG leads with
 1 mm ST segment depression predicted the presence of MVD. After adjusting for age
and gender, more than 3 ECG leads with  1 mm of ST segment depression predicted
the presence of MVD, odds radio 3.79 (95% CI 1.2 to 12.3, p 0.03).
Conclusions: STEMI patients with MVD can be identified based upon the initial
ECG.
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Total Bilirubin Predicts Long Term Clinical Outcomes In No-reflow Patients With
Acute St-segment Elevation Myocardial Infarction During Primary Coronary
Intervention
liu jiangfeng, Sr., Chen Yundai, wang changhua, tian feng, yang junjie, zhang tao
Chinese PLA General Hospital, Beijing, China
Background: Increased oxidative stress and vascular inflammation are main mechanisms
for no reflow onset after acute ST-segment elevation myocardial infarction(STEMI) who
were treated by primary percutaneous coronary intervention (PCI). Recent studies have
been reported that the concentration of total bilirubin (TB), acted as antioxidant, could
preserve coronary flow reserve and coronary microvascular functions and was reversely
associated with in hospital outcomes of primary PCI. However, it is not clear whether
high TB exert favorable effects on prognosis of no reflow patients during PCI. This study
was performed to assess the prognostic role of TB in no reflow patients.
Material and Methods: 143 consecutive patients (age: 65.2912.62 years old) with no
reflow treated by primary PCI was enrolled to study. Patients were divided into two
groups based on the TB concentrations (0.9 mg/dl). No-reflow was diagnosed using 2
different methods after PCI: TIMI flow Grade2 or TIMI flow grade 3 with a TIMI
myocardial perfusion grade(TMPG)1. All patients were retrospectively followed up for
9 years for the all cause death and cardiac death.
Results: There were 31 all cause deaths during follow-up. Of them, 26 patients died
from cardiac cause. Patients with adverse events had lower baseline serum TB levels
(P0.05). All patients were stratified into high TB and low TB groups. The mortality of
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